BRAF molecular testing in cytopathology: Implications for diagnosis, prognosis, and targeted therapeutics

Cancer Cytopathol. 2020 Jan;128(1):9-11. doi: 10.1002/cncy.22209. Epub 2019 Nov 25.
No abstract available

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Genetic Testing*
  • Humans
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / genetics*
  • Molecular Targeted Therapy / methods
  • Mutation
  • Neoplasms / diagnosis*
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Neoplasms / mortality
  • Phosphorylation
  • Precision Medicine / methods
  • Prognosis
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Proto-Oncogene Proteins B-raf / genetics*

Substances

  • Antineoplastic Agents
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf